ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CINGW Cingulate Inc

0.02
0.00 (0.00%)
Jun 04 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cingulate Inc CINGW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.02 17:00:00
Open Price Low Price High Price Close Price Prev Close
0.0126 0.0126 0.0126 0.02 0.02
more quote information »

Recent News

Date Time Source Heading
6/04/20249:08IHNWFeaturedElement79 Gold Corp Continues Fostering Local Community Engagement
5/28/202417:54EDGAR2Form SC 13D/A - General statement of acquisition of..
5/28/202409:20EDGAR2Form 8-K - Current report
5/24/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
5/23/202417:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/21/202409:00GLOBEFDA Clears Cingulate to File for Marketing Approval of..
5/17/202417:01EDGAR2Form S-1 - General form for registration of securities under..
5/13/202408:00EDGAR2Form 8-K - Current report
5/08/202407:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202407:10EDGAR2Form 8-K - Current report
5/08/202407:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
4/30/202405:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
4/16/202417:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
4/01/202408:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
3/19/202416:45GLOBECingulate to Participate in Benzinga All Live Access Event
3/06/202406:45GLOBECingulate to Attend DCAT Week 2024 in New York City
2/13/202406:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
2/06/202416:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
2/02/202409:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
1/29/202408:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
1/29/202406:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
12/01/202309:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
11/13/202316:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
10/17/202314:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
9/21/202313:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
9/13/202316:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
9/11/202309:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
9/11/202306:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
9/08/202316:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
9/05/202308:00GLOBECingulate Announces Presentation of Full Trial Results from..
8/14/202316:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
7/11/202308:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
6/29/202308:00GLOBECingulate Successfully Manufactures Clinical Supply –..
6/14/202315:45GLOBECingulate to Participate in the Healthcare Virtual..
6/08/202307:00GLOBECingulate Completes Phase 3 Adult Trial of CTx-1301..